ERBB2 and breast carcinoma: Interestingly, ~36% of these targets were found to be altered at the transcript (BCL2, CCNE1, CSKN2A1, ELAVL1, ERBB2, ETS1, EZH2, FOXO1, IRAK1, MUC1, MYC, NDRG1, PDCD4, SERPINB5, RPS6B1, SNCG, TIMP3, TP53, and TP53INP1) or the protein (BCL2, CASP3, CCNE1, CDKN1B, ERBB2, MUC1, MYC, PTEN, SERPINB5, TP53) levels in breast cancer based on analyses using genes to system breast cancer (G2SBC) database (Mosca et al., 2010).